Some GLP-1 agonists only require once-weekly dosing
These medicines, on a peripheral level, inhibit stomach emptying and intestinal motility, hence extending satiety signals
Our initial consultation will evaluate your health, goals, and lifestyle to determine the most effective plan for you
For patients currently using licensed injectable GLP-1 receptor agonists in the UK: Once-daily formulations include liraglutide (Victoza) [2] Once-weekly formulations include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide extended-release (Bydureon) [1] [2] If you are participating in a clinical trial involving a GLP-1 patch, you must strictly follow the specific instructions provided by the research team regarding application duration, replacement schedule, and all other aspects of use
It is also prescribed off-label to treat obesity and promote weight loss in individuals who have not been successful with lifestyle modification alone